Deregulation of the ubiquitin-proteasome system is the predominant molecular pathology in OPMD animal models and patients.

Abstract : ABSTRACT: Oculopharyngeal muscular dystrophy (OPMD) is a late-onset progressive muscle disorder caused by a poly-alanine expansion mutation in the Poly(A) Binding Protein Nuclear 1 (PABPN1). The molecular mechanisms that regulate disease onset and progression are largely unknown. In order to identify molecular pathways that are consistently associated with OPMD, we performed an integrated high-throughput transcriptome study in affected muscles of OPMD animal models and patients. The ubiquitin-proteasome system (UPS) was found to be the most consistently and significantly OPMD-deregulated pathway across species. We could correlate the association of the UPS OPMD-deregulated genes with stages of disease progression. The expression trend of a subset of these genes is age-associated and therefore, marks the late onset of the disease, and a second group with expression trends relating to disease-progression. We demonstrate a correlation between expression trends and entrapment into PABPN1 insoluble aggregates of OPMD-deregulated E3 ligases. We also show that manipulations of proteasome and immunoproteasome activity specifically affect the accumulation and aggregation of mutant PABPN1. We suggest that the natural decrease in proteasome expression and its activity during muscle aging contributes to the onset of the disease.
Type de document :
Article dans une revue
Skeletal Muscle, BioMed Central, 2011, 1 (1), pp.15. 〈10.1186/2044-5040-1-15〉
Liste complète des métadonnées

http://www.hal.inserm.fr/inserm-00617211
Contributeur : Ed. Bmc <>
Soumis le : vendredi 26 août 2011 - 15:31:19
Dernière modification le : vendredi 31 août 2018 - 09:13:21
Document(s) archivé(s) le : mardi 13 novembre 2012 - 09:25:37

Identifiants

Collections

Citation

Seyed Anvar, Peter T Hoen, Andrea Venema, Barbara Van Der Sluijs, Baziel Van Engelen, et al.. Deregulation of the ubiquitin-proteasome system is the predominant molecular pathology in OPMD animal models and patients.. Skeletal Muscle, BioMed Central, 2011, 1 (1), pp.15. 〈10.1186/2044-5040-1-15〉. 〈inserm-00617211〉

Partager

Métriques

Consultations de la notice

459

Téléchargements de fichiers

230